Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunjan L Shah

Showing results (21-30 of 130) with videos related to

Pageof 13
Sort By:
Bone Marrow Transplantation|February 13, 2024
Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantationGiovanna Melica, Elaina Preston, Meighan Palazzo, et al.
British Journal of Haematology|July 6, 2016
Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantationGunjan L Shah, Joachim Yahalom, Matthew J Matasar, et al.
Bone Marrow Research|November 11, 2016
Cost Implications of Comorbidity for Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma Using SEER-MedicareGunjan L Shah, Aaron Winn, Pei-Jung Lin, et al.
Leukemia & Lymphoma|June 28, 2021
Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortalityMaximilian Stahl, Varun Narendra, Justin Jee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2015
Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare DatabaseGunjan L Shah, Aaron N Winn, Pei-Jung Lin, et al.
Clinical Pharmacokinetics|December 3, 2021
Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing RegimensGunjan L Shah, Jaap Jan Boelens, Dean Carlow, et al.
Cancers|June 13, 2025
Post-Transplant Pain and Paralysis: Neurologic Amyotrophy as an Atypical Cause of Shoulder Dysfunction Following Hematopoietic Stem Cell TransplantFranchesca König, Chanel Davidoff, Katarzyna Ibanez, et al.
Leukemia & Lymphoma|January 13, 2017
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantationGunjan L Shah, Heather Landau, Dory Londono, et al.
Transplantation and Cellular Therapy|July 11, 2025
Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell TransplantStephen Eng, Grashma Vadakkel, Samantha Brown, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 15, 2018
Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17pSandy W Wong, Ute Hegenbart, Giovanni Palladini, et al.
Pageof 13

Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Bone Marrow Transplantation|February 13, 2024
Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantationGiovanna Melica, Elaina Preston, Meighan Palazzo, et al.
British Journal of Haematology|July 6, 2016
Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantationGunjan L Shah, Joachim Yahalom, Matthew J Matasar, et al.
Bone Marrow Research|November 11, 2016
Cost Implications of Comorbidity for Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma Using SEER-MedicareGunjan L Shah, Aaron Winn, Pei-Jung Lin, et al.
Leukemia & Lymphoma|June 28, 2021
Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortalityMaximilian Stahl, Varun Narendra, Justin Jee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2015
Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare DatabaseGunjan L Shah, Aaron N Winn, Pei-Jung Lin, et al.
Clinical Pharmacokinetics|December 3, 2021
Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing RegimensGunjan L Shah, Jaap Jan Boelens, Dean Carlow, et al.
Cancers|June 13, 2025
Post-Transplant Pain and Paralysis: Neurologic Amyotrophy as an Atypical Cause of Shoulder Dysfunction Following Hematopoietic Stem Cell TransplantFranchesca König, Chanel Davidoff, Katarzyna Ibanez, et al.
Leukemia & Lymphoma|January 13, 2017
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantationGunjan L Shah, Heather Landau, Dory Londono, et al.
Transplantation and Cellular Therapy|July 11, 2025
Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell TransplantStephen Eng, Grashma Vadakkel, Samantha Brown, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 15, 2018
Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17pSandy W Wong, Ute Hegenbart, Giovanni Palladini, et al.
Pageof 13